Access For All
JDRF's #AccessForAll campaign helped secure a $271.3M bipartisan commitment to subsidise Continuous and Flash Glucose Monitors for all Australians living with type 1 diabetes.
More technology for more people
Life-saving and life-changing technologies to measure blood glucose and deliver insulin in response to need are the foundation of type 1 diabetes (T1D) treatment and care in the 21st century.
JDRF believes that no Australian living with T1D should have to worry about how they will afford this technology. It is not acceptable, equitable or justifiable that access to these technologies is dictated by age or wealth rather than need and benefit.
That’s why we are thrilled JDRF’s #AccessForAll campaign helped secure a bipartisan commitment of $273.1 million for continuous and flash glucose monitors to be subsidised for all of Australia’s type 1 diabetes (T1D) community. This means that:
- CGM and flash glucose monitoring devices will be available under the National Diabetes Services Scheme for those aged 21 and older who don’t already have access from 1 July 2022 for a maximum co-contribution of $32.50 per month.
- People who meet the existing eligibility criteria such as under 21s, concession card holders and pregnant women or those planning pregnancy will continue to receive unchanged, fully subsidised access to CGM and Flash Glucose Monitoring products.
The human impact
Madison, CGM user
“I can now approach my 21st birthday with pure excitement of what my future holds, free of any worry of losing access to my CGM. All of us can now have access to this technology, that has given us complete control over our type 1 diabetes”
Shanna, Flash GM user
"Knowing that I will now be able to afford my Flash Glucose Monitors each month is a huge weight off my shoulders. I know that my diabetes control will greatly improve with access to this life-saving technology.”
Daniel, CGM and pump user
”I'm so excited by the bipartisan commitment to make CGM technology affordable to all because I've seen firsthand how beneficial it will be. My control since going on the CGM early last year has been the best it has been since I was diagnosed 27 years ago and it's sensational to know the entire T1D community will see the benefits soon"
STAY UPDATED ON JDRFs ADVOCACY
I am interested in hearing more about…
